| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-12,998 | -5,685 | -4,808 | -5,233 | -6,702 |
|
Operation and Maintenance Expenses
|
-111 | -111 | -105 | -906 | -402 |
|
Research and Development Expenses
|
-11,137 | -9,204 | -10,623 | -19,012 | -18,693 |
|
Taxes Other Than Income Taxes
|
0 | 0 | 605 | 0 | 0 |
|
Operating Income/Expenses
|
-24,246 | -15,000 | -14,931 | -25,151 | -25,797 |
|
Total Operating Profit/Loss
|
-24,246 | -15,000 | -14,931 | -25,151 | -25,797 |
| Total Net Finance Income/Expense
|
-1,788 | 779 | 1,056 | 1,551 | 821 |
| Net Investment Income
|
1,632,424 | 1,632,424 | -182 | -1,224 | -6,084 |
| Irregular Income/Expenses
|
0 | -29 | -957 | -4,244 | 0 |
|
Non-Operating Income/Expenses, Total
|
4,184,079 | 1,633,174 | -83 | -3,917 | -5,263 |
|
Pretax Income
|
4,159,833 | 1,618,174 | -15,014 | -29,068 | -31,060 |
|
Provision for Income Tax
|
-382,646 | -382,646 | 0 | 0 | -- |
|
Net Income from Continuing Operations
|
3,189,895 | 1,235,528 | -15,014 | -29,068 | -31,060 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,189,895 | 1,235,528 | -15,014 | -29,068 | -31,060 |
|
Net Income after Non-Controlling/Minority Interests
|
3,189,895 | 1,235,528 | -15,014 | -29,068 | -31,060 |
|
Net Income Available to Common Stockholders
|
3,189,895 | 1,235,528 | -15,014 | -29,068 | -31,060 |
|
Diluted Net Income Available to Common Stockholders
|
3,189,895 | 1,235,528 | -15,014 | -29,068 | -31,060 |
| Basic EPS
|
8.46k | 6.49k | -175.20 | -374.40 | -405.60 |
| Diluted EPS
|
7.90k | 6.12k | -175.20 | -374.40 | -405.60 |
|
Basic Weighted Average Shares Outstanding
|
648.0640 | 190.4010 | 85.4750 | 77.3940 | 76.6450 |
|
Diluted Weighted Average Shares Outstanding
|
713.7440 | 202.0790 | 85.4750 | 77.3940 | 76.6450 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
4,161,608 | 1,617,382 | -16,083 | -30,633 | -31,895 |
|
EBITDA
|
4,161,886 | 1,617,714 | -15,538 | -29,798 | -31,118 |
|
Normalized EBITDA
|
4,170,288 | -1,280,369 | -13,074 | -23,946 | -26,423 |
|
Normalized Income
|
3,196,364.5400 | -977,158.3705 | -12,550 | -23,216 | -26,365 |
|
Total Unusual Items
|
8,402 | -2,898,083 | 2,464 | 5,852 | 4,695 |
|
Total Unusual Items Excluding Goodwill
|
8,402 | -2,898,083 | 2,464 | 5,852 | 4,695 |
|
Tax Effect of Unusual Items
|
1,932.4600 | -685,396.6295 | 0 | 0 | 0 |
12/31/2022 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade